Showing results (61-70 of 497) with videos related to
Sort By:
Pageof 50
Clinical Chemistry and Laboratory Medicine|March 24, 2007
Clinical indications for plasma protein assays: transthyretin (prealbumin) in inflammation and malnutritionA Myron Johnson, Giampaolo Merlini, Joanna Sheldon, et al.Eupa Open Proteomics|June 15, 2018
Systemic amyloidoses and proteomics: The state of the artFrancesca Lavatelli, Andrea di Fonzo, Giovanni Palladini, et al.Blood|May 31, 2024
Patients with a cardiac complete response in AL amyloidosis have survival rates similar to those of a matched general populationEli Muchtar, Susan Geyer, Giampaolo Merlini, et al.Biochimica Et Biophysica Acta|October 4, 2005
Clinical aspects of systemic amyloid diseasesLaura Obici, Vittorio Perfetti, Giovanni Palladini, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2005
Immunoglobulin M monoclonal gammopathies of undetermined significance and indolent Waldenstrom's macroglobulinemia recognize the same determinants of evolution into symptomatic lymphoid disorders: proposal for a common prognostic scoring systemLuca Baldini, Maria Goldaniga, Andrea Guffanti, et al.Blood|September 6, 2013
Primary therapy of Waldenstrom macroglobulinemia (WM) with weekly bortezomib, low-dose dexamethasone, and rituximab (BDR): long-term results of a phase 2 study of the European Myeloma Network (EMN)Meletios A Dimopoulos, Ramón García-Sanz, Maria Gavriatopoulou, et al.Blood|November 23, 2016
BDR in newly diagnosed patients with WM: final analysis of a phase 2 study after a minimum follow-up of 6 yearsMaria Gavriatopoulou, Ramón García-Sanz, Efstathios Kastritis, et al.Journal of Translational Medicine|August 3, 2010
Synergy of combined doxycycline/TUDCA treatment in lowering Transthyretin deposition and associated biomarkers: studies in FAP mouse modelsIsabel Cardoso, Diana Martins, Tania Ribeiro, et al.Haematologica|January 12, 2005
How we treat Waldenström's macroglobulinemiaMeletios A Dimopoulos, Giampaolo Merlini, Veronique Leblond, et al.Advances in Therapy|October 27, 2015
Light Chain Amyloidosis: Patient Experience Survey from the Amyloidosis Research ConsortiumIsabelle Lousada, Raymond L Comenzo, Heather Landau, et al.Pageof 50